BTIG Reiterates Buy on Ascentage Pharma Group, Maintains $48 Price Target

Benzinga · 3d ago
BTIG analyst Jeet Mukherjee reiterates Ascentage Pharma Group (NASDAQ:AAPG) with a Buy and maintains $48 price target.